FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing (R)- quinuclidin-3-yl 6-((3S,4R)-4-(4-amino-5-chloro-2-methoxybenzamide)-3-methoxypiperidin-1-yl)hexanoate or salt thereof, involving: 1) converting a compound which is 4-amino-3-methoxypiperidine-1-carboxylate to a salt; 2) converting the ethyl 4-amino-3-methoxypiperidine-1-carboxylate salt into ethyl 4-(diphenylamine)-3-methoxypiperidine-1-carboxylate 3) treating ethyl 4-(diphenylamino)-3-methoxypiperidine-1-carboxylate with hydroxide or hydride of an alkali metal to obtain 3-methoxy-N,N-diphenylpiperidine-4-amine 4) obtainijng a chiral salt of the cis-isomer of 3-methoxy-N,N-diphenylpiperidine-4-amine by bringing 3-methoxy-N,N-diphenylpiperidine-4-amine into contact with a chiral splitting agent and extracting the obtained chiral salt of the cis-isomer of 3-methoxy-N,N-diphenylpiperidine-4-amine; optional recrystalisation of product 4; converting product 4 or 5 to a base to obtain product 4 or 5 in form of a free base; 7) bringing product 6 into contact with ethyl 6-bromohexanoate to obtain ethyl 6-((3S,4R)-4-(diphenylamine)-3-methoxypiperidin-1-yl)hexanoate 8) esterification of ethyl 6-((3S,4R)-4-(diphenylamine)-3-methoxypiperidin-1-yl)hexanoate using (R)-quinuclidin-3-ol with a Lewis acid to obtain (R)- quinuclidin-3-yl 6-((3S,4R)-4-(diphenylamine)-3-methoxypiperidin-1-yl)hexanoate 9) removing protection from the 4-amine group of product 8 to obtain (R- quinuclidin-3-yl 6- [(3S,4R)-4-amino-3-methoxypiperidin-1-yl)hexanoate; 10) acylation of product 9 4-amino-5-chloro-2-methoxybenzoic acid to obtain (R)- quinuclidin-3-yl 6-((38,4R)-4-(4-amino-5-chloro-2-methoxybenzamide)-3-methoxypiperidin-1-yl)hexanoate; 11) optional conversion of product 10 into a salt.
EFFECT: method increases output of the end product and reduces content of impurities.
7 cl, 3 ex, 6 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
STEREOISOMER COMPOUNDS AND METHODS OF TREATING GASTROINTESTINAL DISORDERS AND CENTRAL NERVOUS SYSTEM DISORDERS | 2005 |
|
RU2374244C2 |
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | 2013 |
|
RU2660429C2 |
ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2707749C2 |
ANTIBACTERIAL PIPERIDINE DERIVATIVES | 2006 |
|
RU2424240C2 |
COMPOUNDS REPRESENTING STYRENE DERIVATIVES FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | 2008 |
|
RU2494089C2 |
BICYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS | 2018 |
|
RU2776846C2 |
METHOD OF PREPARING 1-(ALKOXYMETHYL)PYRROLE COMPOUNDS | 1994 |
|
RU2137758C1 |
METHOD OF 4-HYDROXYPROLINE SUBSTRUCTURE-CONTAINING COMPOUND SYNTHESIS | 2003 |
|
RU2392265C2 |
METHOD FOR SYNTHESIS OF POLYHYDROXY STILBENE COMPOUNDS | 2008 |
|
RU2474570C2 |
COMPOUNDS FOR TREATING COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2703995C2 |
Authors
Dates
2011-05-20—Published
2006-08-31—Filed